Please find below a recent posting to AVAC's Advocates' Network regarding a sign-on letter to support evidence-based decision-making in HIV prevention research:
March 17, 2011
Today, AVAC and a number of US-based AIDS advocacy allies released a sign-on statement <http://salsa.democracyinaction.org/o/1837/p/salsa/web/common/public/signup?si...> supporting the thorough, evidence-based review process of TDF/FTC (Truvada) as an HIV prevention strategy for gay men and other men who have sex with men (MSM), as well as transgender women who have sex with men (TSM). This statement lays out a rationale for regulatory agencies both in the US and around the world to fully explore the potential of PrEP as a new prevention tool for these communities that are under-served by current prevention and treatment worldwide. We hope you will join us in supporting the process of a full and thorough data analysis as part of an independent regulatory process.
This sign-on statement and a forthcoming fact sheet are designed to allow advocates to understand the issues and add their voices, once they have come to their own decisions. They have been developed by and for organizations, individuals and communities who are concerned about a new media campaign launched by a US-based AIDS health care provider that seeks to stymie the regulatory exploration of PrEP as a potential prevention tool.
The context for these documents includes recent results from the iPrEx PrEP trial <http://www.avac.org/ht/d/sp/i/3619/pid/3619> , which showed that daily TDF/FTC (Truvada) reduced the risk of HIV by approximately 44 percent in gay men, transgender women and other men who have sex with men. These results are cause for excitement. They are also cause for caution. Neither AVAC nor any of the many stakeholders working on PrEP have advocated for immediate, widespread implementation of PrEP. However, as we recently noted <http://www.avac.org/ht/d/sp/i/32883/pid/32883> , we have called for accelerated implementation research and regulatory review to answer key unanswered questions.
Please add your voice and make it clear that the HIV/AIDS community supports evidence-based prevention and rigorous, unbiased regulatory review as core components of an effective AIDS response.
We welcome sign-ons from individuals, organizations and coalitions. <http://salsa.democracyinaction.org/o/1837/p/salsa/web/common/public/signup?si...>
More information on PrEP research and related issues can be found online at www.avac.org/prep.